CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies

NCT03312205 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma of Bone (Diagnosis)

Interventions

BIOLOGICAL: Autologous CAR-T cells

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.

Collaborators

[object Object]
[object Object]